• Status: Closed

  • Key features: Investment of up to £4 million in collaborative R&D projects to address the UK’s need for improved analytical technologies that support the development of current and next generation biopharmaceutical products.

  • Programme: Collaborative research and development

  • Award: Up to £4 million

  • Opens: 14 Sep 2015, 00:00

  • Registration closes: 14 Oct 2015, 12:00

  • Closes: 21 Oct 2015, 12:00

  • Support phone number: 0300 321 4357

Analytical technologies for biopharmaceuticals

Summary

Innovate UK is to invest up to £4 million in collaborative R&D projects to address the UK's need for improved analytical technologies that support the development of current and next generation biopharmaceutical products.
 
The aim of this competition is to advance the industry by addressing sector-specific challenges relating to analytical technologies for testing and characterising biopharmaceutical products and monitoring processes, as well as the supporting informatics tools.
 
We are seeking proposals that bring together biopharmaceutical producers, research organisations, processing specialists and analytical and process control equipment manufacturers to generate innovative solutions.
 
Proposals must be collaborative and led by a business. We expect to fund mainly industrial research, but will also consider projects with elements of experimental development. Small businesses could receive up to 70% of their eligible project costs, medium- sized businesses 60% and large businesses 50%.
 
We expect projects to range in size from total costs of £500,000 to £1.5 million, although we may consider projects outside this range. This is a 2-stage competition that opens for applicants on 14 September 2015. The deadline for expressions of interest is at noon on 21 October 2015.
 
There will be briefing events for potential applicants in London on 16 September 2015 and Darlington on 22 September 2015. A briefing webinar will also be available.

Scope

This competition seeks to advance the development and commercialisation of biopharmaceutical products and processes by improving the analytical technologies used to develop formulations, monitor processes and characterise products, as well as developing the associated informatics required to implement Quality by Design and process analytical technology approaches.

Out of scope

Projects relating to the development of companion diagnostics, clinical assays and the discovery of new targets and therapies are not within the scope of this competition.
 

Key dates

Competition opens 14 September 2015
Competition briefings

16 September 2015 – London

22 September 2015 – Darlington

Registration deadline noon 14 October 2015
Expressions of interest (EOI) deadline noon 21 October 2015
Stage 2 opens for invited applicants 16 November 2015
Deadline for invited applications noon 7 January 2016

 

Supporting documents & links